Skip to main content

Advertisement

Log in

Treatment failure definitions for non-purulent skin and soft tissue infections: a systematic review

  • Original Paper
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Objective

There is currently no uniform definition for antimicrobial treatment failure for adults with non-purulent skin and soft tissue infections (SSTIs). The objective of this systematic review was to identify treatment failure definitions and their common components in the literature.

Methods

Five electronic databases were searched from inception to March 2019. Two independent reviewers identified studies involving adults (age ≥ 18 years) with non-purulent SSTIs in which antimicrobial treatment failure was a defined outcome. There were no language restrictions. Only randomized trials or observational studies were included.

Results

After screening 4953 abstracts, 26 studies (N = 6629 patients) met full inclusion criteria. Reported treatment failure ranged from 0 to 29.5%. The most common definition components were hospital admission (78.9%), change in antibiotics (65.4%), and persistent or worsening signs and symptoms of infection (34.6%). Only one study listed specific criteria for persistent or worsening signs and symptoms of infection.

Conclusions

For studies involving non-purulent SSTIs, the outcome of treatment failure is inconsistently defined and reported failure rates are highly variable. This systematic review has highlighted the need for more robust treatment failure definitions for non-purulent SSTIs. Research should focus on the development of a uniform treatment failure definition that should be used in future studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Stevens DL, Eron LL. Cellulitis and soft-tissue infections. Ann Intern Med. 2009;150:ITC11.

    PubMed  Google Scholar 

  2. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168:1585–91.

    Article  Google Scholar 

  3. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA Jr. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51:291–8. https://doi.org/10.1016/j.annemergmed.2007.12.004.

    Article  PubMed  Google Scholar 

  4. Pallin DJ, Camargo CA Jr, Schuur JD. Skin infections and antibiotic stewardship: analysis of emergency department prescribing practices, 2007–2010. West J Emerg Med. 2014;15:282–9. https://doi.org/10.5811/westjem.2013.8.18040.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Venkatesh AK, Dai Y, Ross JS, Schuur JD, Capp R, Krumholz HM. Variation in US hospital emergency department admission rates by clinical condition. Med Care. 2015;53:237–44. https://doi.org/10.1097/MLR.0000000000000261.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yadav K, Suh KN, Eagles D, MacIsaac J, Ritchie D, Bernick J, et al. Predictors of oral antibiotic treatment failure for non-purulent skin and soft tissue infections in the emergency department. Acad Emerg Med. 2018;2018:13492.

    Article  Google Scholar 

  7. Talan DA, Salhi BA, Moran GJ, Mower WR, Hsieh YH, Krishnadasan A, et al. Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection. West J Emerg Med. 2015;16:89–97.

    Article  Google Scholar 

  8. Pollack CV Jr, Amin A, Ford WT Jr, Finley R, Kaye KS, Nguyen HH, et al. Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital. J Emerg Med. 2015;48:508–19.

    Article  Google Scholar 

  9. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–52. https://doi.org/10.1093/cid/ciu444.

    Article  PubMed  Google Scholar 

  10. Lymphoedema Support Network; British Lymphology Society. Consensus document on the management of cellulitis in lymphoedema; December 2016. https://www.lymphoedema.org/images/pdf/CellulitisConsensus.pdf. Accessed 6 Aug 2018.

  11. Kwak YG, Choi SH, Kim T, Park SY, Seo SH, Kim MB, et al. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother. 2017;49:301–25. https://doi.org/10.3947/ic.2017.49.4.301.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Obaitan I, Dwyer R, Lipworth AD, Kupper TS, Camargo CA Jr, Hooper DC, et al. Failure of antibiotics in cellulitis trials: a systematic review and meta-analysis. Am J Emerg Med. 2016;34:1645–52. https://doi.org/10.1016/j.ajem.2016.05.064.

    Article  PubMed  Google Scholar 

  13. U.S. Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER). Acute bacterial skin and skin structure infections: developing drugs for treatment. http://www.fda.gov/downloads/Drugs/…/Guidances/ucm071185.pdf. Accessed 6 Aug 2018.

  14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. https://doi.org/10.1371/journal.pmed.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wise R. The pharmacokinetics of the oral cephalosporins—a review. J Antimicrob Chemother. 1990;26 Suppl E:13–20.

    Article  CAS  Google Scholar 

  16. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.

    Article  Google Scholar 

  17. Wells GA, Shea B, O’Connel D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed 14 Aug 2018.

  18. Yadav K, Gatien M, Corrales-Medina V, Stiell I. Antimicrobial treatment decision for non-purulent skin and soft tissue infections in the emergency department. CJEM. 2017;19:175–80. https://doi.org/10.1017/cem.2016.347.

    Article  PubMed  Google Scholar 

  19. Smith E, Patel M, Thomas KS. Which outcomes are reported in cellulitis trials? Results of a review of outcomes included in cellulitis trials and a patient priority setting survey. Br J Dermatol. 2018;178:1028–34.

    Article  CAS  Google Scholar 

  20. Kilburn SA, Featherstone P, Higgins B, Brindle R. Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev. 2010;6:004299. https://doi.org/10.1002/14651858.cd004299.pub2.

    Article  Google Scholar 

  21. Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET handbook: version 1.0. Trials. 2017;18:280.

    Article  Google Scholar 

  22. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18:1007–19.

    Article  CAS  Google Scholar 

  23. Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine. 2005;30:1331–4.

    Article  Google Scholar 

  24. Conway EL, Sellick JA, Kurtzhalts K, Mergenhagen KA. Obesity and heart failure as predictors of failure in outpatient skin and soft tissue infections. Antimicrob Agents Chemother. 2017;61:e02389–16.

    Article  Google Scholar 

  25. Kaufman KR, Thurber KM, O’Meara JG, Langworthy DR, Kashiwagi DT. Evaluation of cephalexin failure rates in morbidly obese patients with cellulitis. J Clin Pharm Ther. 2016;41:409–13.

    Article  CAS  Google Scholar 

  26. Kiani R. Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections. Eur J Clin Microbiol Infect Dis. 1991;10:880–4.

    Article  CAS  Google Scholar 

  27. Madaras-Kelly KJ, Remington RE, Oliphant CM, Sloan KL, Bearden DT. Efficacy of oral beta-lactam versus non-beta-lactam treatment of uncomplicated cellulitis. Am J Med. 2008;121:419–25.

    Article  CAS  Google Scholar 

  28. Madaras-Kelly KJ, Arbogast R, Jue S. Increased therapeutic failure for cephalexin versus comparator antibiotics in the treatment of uncomplicated outpatient cellulitis. Pharmacotherapy. 2000;20:199–205.

    Article  CAS  Google Scholar 

  29. Moran GJ, Krishnadasan A, Mower WR, Abrahamian FM, LoVecchio F, Steele MT, et al. Effect of cephalexin plus trimethoprim-sulfamethoxazole vs cephalexin alone on clinical cure of uncomplicated cellulitis: a randomized clinical trial. JAMA. 2017;317:2088–96.

    Article  CAS  Google Scholar 

  30. Theofiles M, Maxson J, Herges L, Marcelin A, Angstman KB. Cellulitis in obesity: adverse outcomes affected by increases in body mass index. J Prim Care Community Health. 2015;6:233–8.

    Article  Google Scholar 

  31. Wells RD, Mason P, Roarty J, Dooley M. Comparison of initial antibiotic choice and treatment of cellulitis in the pre- and post-community-acquired methicillin-resistant Staphylococcus aureus eras. Am J Emerg Med. 2009;27:436–9.

    Article  Google Scholar 

  32. Bader MS, Twells L, Hawboldt J. Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid. South Med J. 2011;104:789–93.

    Article  Google Scholar 

  33. Chan JC. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology. Adv Ther. 1995;12:139–46.

    CAS  PubMed  Google Scholar 

  34. Gentry LO. Treatment of skin, skin structure, bone, and joint infections with ceftazidime. Am J Med. 1985;79:67–74.

    Article  CAS  Google Scholar 

  35. Grayson ML, McDonald M, Gibson K, Athan E, Munckhof WJ, Paull P, et al. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults. Clin Infect Dis. 2002;34:1440–8.

    Article  CAS  Google Scholar 

  36. Housman E, Livings SE, Knee A, Schimmel J. Improving management of hospitalized adults with uncomplicated cellulitis or cutaneous abscess. Open Forum Infect Dis. 2017;4:ofx094.

    Article  Google Scholar 

  37. Leder K, Turnidge JD, Grayson ML. Home-based treatment of cellulitis with twice-daily cefazolin. Med J Aust. 1998;169:519–22.

    Article  CAS  Google Scholar 

  38. Tan JS, File TM, Salstrom SJ. Timentin versus moxalactam in the treatment of skin and soft tissue infections. Am J Med. 1985;79:130–3.

    Article  CAS  Google Scholar 

  39. Yadav K, Suh KN, Eagles D, Thiruganasambandamoorthy V, Wells GA, Stiell IG. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis. Am J Emerg Med. 2019. https://doi.org/10.1016/j.ajem.2019.02.023.

    Article  PubMed  Google Scholar 

  40. Zhang J, Moore E, Bousfield R. OPAT for cellulitis: its benefits and the factors that predispose to longer treatment. Eur J Clin Microbiol Infect Dis. 2016;35:1013–5. https://doi.org/10.1007/s10096-016-2631-y.

    Article  CAS  PubMed  Google Scholar 

  41. Aboltins CA, Hutchinson AF, Sinnappu RN, Cresp D, Risteski C, Kathirgamanathan R, et al. Oral versus parenteral antimicrobials for the treatment of cellulitis: a randomized non-inferiority trial. J Antimicrob Chemother. 2015;70:581–6. https://doi.org/10.1093/jac/dku397.

    Article  CAS  PubMed  Google Scholar 

  42. Cieri B, Conway EL, Sellick JA, Mergenhagen KA. Identification of risk factors for failure in patients with skin and soft tissue infections. Am J Emerg Med. 2019;37:48–52.

    Article  Google Scholar 

  43. Dalen D, Fry A, Campbell SG, Eppler J, Zed PJ. Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial. Emerg Med J. 2018;35:492–8. https://doi.org/10.1136/emermed-2017-207420.

    Article  PubMed  Google Scholar 

  44. Hepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med. 2004;164:1669–74.

    Article  CAS  Google Scholar 

  45. Jenkins TC, Knepper BC, Sabel AL, Sarcone EE, Long JA, Haukoos JS, et al. Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess. Arch Intern Med. 2011;171:1072–9.

    PubMed  Google Scholar 

  46. Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clin Infect Dis. 2010;51:895–903.

    Article  Google Scholar 

  47. Murray H, Stiell I, Wells G. Treatment failure in emergency department patients with cellulitis. CJEM. 2005;7:228–34.

    Article  Google Scholar 

  48. Peterson D, McLeod S, Woolfrey K, McRae A. Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis. Acad Emerg Med. 2014;21:526–31.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Natalie LeClair for providing peer review of the electronic search strategy.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Krishan Yadav.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 31 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yadav, K., Nath, A., Suh, K.N. et al. Treatment failure definitions for non-purulent skin and soft tissue infections: a systematic review. Infection 48, 75–83 (2020). https://doi.org/10.1007/s15010-019-01347-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-019-01347-w

Keywords

Navigation